Rapamycin Inhibits Cystogenesis by Cystic Epithelial Cells Derived From Human Autosomal Dominant Polycystic Kidneys

American Journal of Pharmacology and Toxicology - United States
doi 10.3844/ajptsp.2006.79.82
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Science Publications

Related search

Ciliary Exclusion of Polycystin-2 Promotes Kidney Cystogenesis in an Autosomal Dominant Polycystic Kidney Disease Model

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

CD8+ T Cells Modulate Autosomal Dominant Polycystic Kidney Disease Progression

Kidney International
Nephrology
2018English

Ectopic (Pelvic) Autosomal Dominant Polycystic Kidney Disease

Internal Medicine
Internal MedicineMedicine
2010English

TRPP2 and Autosomal Dominant Polycystic Kidney Disease

Biochimica et Biophysica Acta - Molecular Basis of Disease
Molecular MedicineMolecular Biology
2007English

Rapamycin for Treatment of Type I Autosomal Dominant Polycystic Kidney Disease (RAPYD-study): A Randomized, Controlled Study

Nephrology Dialysis Transplantation
MedicineTransplantationNephrology
2012English

Predictors of Autosomal Dominant Polycystic Kidney Disease Progression

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Recent Advances in Autosomal-Dominant Polycystic Kidney Disease

Internal Medicine Journal
Internal Medicine
2016English

Interstitial Disease of Autosomal Dominant Polycystic Kidney Disease

Journal of Physiology Studies
2014English

Seminal Vesicles in Autosomal Dominant Polycystic Kidney Disease

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy